McKeon C, Eanes R Z, Fall R R, Tasset D M, Wolf B
Clin Chim Acta. 1980 Feb 28;101(2-3):217-33. doi: 10.1016/0009-8981(80)90246-6.
Antiserum prepared against homogeneous pig heart propionyl CoA carboxylase cross-reacted with human propionyl CoA carboxylase, and was used to demonstrate the presence of immunological cross-reacting material in extracts from the livers of three patients and from fibroblasts of four patients with propionic acidemia representing three major propionyl CoA carboxylase-deficient genetic complementation groups, pcc A, pcc C and bio. Since the quantity of cross-reacting material in the propionyl CoA carboxylase-deficient livers and enzyme-deficient fibroblast cell lines was comparable to that in normal tissues while showing less than five percent of the normal enzyme activity, these patients must synthesize normal or near-normal quantities of an enzymatically inactive propionyl CoA carboxylase protein. In addition, no appreciable change in the amount of cross-reacting material was found in the biotin-responsive bio fibroblasts after incubation with supplemental biotin despite a sixteen-fold increase in enzyme activity suggesting that the defect in the bio mutant involves the activation rather than the synthesis of a pre-existing normal apoenzyme.
针对纯合猪心脏丙酰辅酶A羧化酶制备的抗血清与人类丙酰辅酶A羧化酶发生交叉反应,并用于证明三名丙酸血症患者肝脏提取物和四名丙酸血症患者成纤维细胞提取物中存在免疫交叉反应物质,这些患者代表三个主要的丙酰辅酶A羧化酶缺陷基因互补组,即pcc A、pcc C和bio。由于丙酰辅酶A羧化酶缺陷肝脏和酶缺陷成纤维细胞系中的交叉反应物质数量与正常组织中的相当,而酶活性不到正常的5%,这些患者必定合成了正常或接近正常数量的无酶活性的丙酰辅酶A羧化酶蛋白。此外,在生物素反应性bio成纤维细胞与补充生物素一起孵育后,尽管酶活性增加了16倍,但未发现交叉反应物质的量有明显变化,这表明bio突变体中的缺陷涉及预先存在的正常脱辅基酶的激活而非合成。